LENZ Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €252.28M +43.7% €102.73M +127.9% 40.7% +0.15 pp N/A N/A
    (estimated) €175.61M +69.1% €45.07M -958.9% 25.7% +0.31 pp N/A N/A
    (estimated) €103.86M +142.0% -€5.25M -91.2% -5.1% +1.3 pp N/A N/A
    (estimated) €42.92M +285.5% -€59.64M -5.3% -139.0% +4.3 pp N/A N/A
    (estimated) €11.13M +∞% -€62.98M +46.6% -565.7% -5.7 pp N/A N/A
    €0.00 +NaN% -€42.95M -60.1% N/A -€50.85M -2.4% N/A
    €0.00 -100.0% -€107.58M +23.4% N/A -€52.08M -25.8% N/A
    €12.95M +∞% -€87.21M +42.8% -673.7% -6.7 pp -€70.24M +72.8% -542.6% -5.4 pp
    €0.00 +NaN% -€61.07M +3.5% N/A -€40.66M +556.5% N/A
    €0.00 +NaN% -€59.01M +62,627.5% N/A -€6.19M +37,668.4% N/A
    €0.00 -€94.07K N/A -€16.40K N/A

    Notifications